Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 6
2005 4
2007 5
2008 12
2009 4
2010 3
2011 9
2012 4
2013 2
2014 1
2016 1
2017 2
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.
Vicente E, Villar R, Pérez-Silanes S, Aldana I, Goldman RC, Mong A. Vicente E, et al. Among authors: aldana i. Infect Disord Drug Targets. 2011 Apr;11(2):196-204. doi: 10.2174/187152611795589735. Infect Disord Drug Targets. 2011. PMID: 21470099 Free article. Review.
Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.
Quiliano M, Pabón A, Moles E, Bonilla-Ramirez L, Fabing I, Fong KY, Nieto-Aco DA, Wright DW, Pizarro JC, Vettorazzi A, López de Cerain A, Deharo E, Fernández-Busquets X, Garavito G, Aldana I, Galiano S. Quiliano M, et al. Among authors: aldana i. Eur J Med Chem. 2018 May 25;152:489-514. doi: 10.1016/j.ejmech.2018.04.038. Epub 2018 Apr 24. Eur J Med Chem. 2018. PMID: 29754074
Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Bonilla-Ramirez L, Rios A, Quiliano M, Ramirez-Calderon G, Beltrán-Hortelano I, Franetich JF, Corcuera L, Bordessoulles M, Vettorazzi A, López de Cerain A, Aldana I, Mazier D, Pabón A, Galiano S. Bonilla-Ramirez L, et al. Among authors: aldana i. Eur J Med Chem. 2018 Oct 5;158:68-81. doi: 10.1016/j.ejmech.2018.08.063. Epub 2018 Aug 30. Eur J Med Chem. 2018. PMID: 30199706
Primaquine-quinoxaline 1,4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen species.
Bonilla-Ramírez L, Galiano S, Quiliano M, Aldana I, Pabón A. Bonilla-Ramírez L, et al. Among authors: aldana i. Malar J. 2019 Jun 19;18(1):201. doi: 10.1186/s12936-019-2825-8. Malar J. 2019. PMID: 31217011 Free PMC article.
Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity.
Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A. Rivera G, et al. Among authors: aldana i. Curr Med Chem. 2008;15(10):1025-43. doi: 10.2174/092986708784049621. Curr Med Chem. 2008. PMID: 18393860 Review.
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Quiliano M, Pabón A, Ramirez-Calderon G, Barea C, Deharo E, Galiano S, Aldana I. Quiliano M, et al. Among authors: aldana i. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1820-1825. doi: 10.1016/j.bmcl.2017.02.049. Epub 2017 Feb 21. Bioorg Med Chem Lett. 2017. PMID: 28291694
Exploring the scope of new arylamino alcohol derivatives: Synthesis, antimalarial evaluation, toxicological studies, and target exploration.
Quiliano M, Mendoza A, Fong KY, Pabón A, Goldfarb NE, Fabing I, Vettorazzi A, López de Cerain A, Dunn BM, Garavito G, Wright DW, Deharo E, Pérez-Silanes S, Aldana I, Galiano S. Quiliano M, et al. Among authors: aldana i. Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):184-198. doi: 10.1016/j.ijpddr.2016.09.004. Epub 2016 Sep 28. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27718413 Free PMC article.
Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
Torres E, Moreno-Viguri E, Galiano S, Devarapally G, Crawford PW, Azqueta A, Arbillaga L, Varela J, Birriel E, Di Maio R, Cerecetto H, González M, Aldana I, Monge A, Pérez-Silanes S. Torres E, et al. Among authors: aldana i. Eur J Med Chem. 2013 Aug;66:324-34. doi: 10.1016/j.ejmech.2013.04.065. Epub 2013 May 30. Eur J Med Chem. 2013. PMID: 23811257 Free article.
ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model.
Moles E, Galiano S, Gomes A, Quiliano M, Teixeira C, Aldana I, Gomes P, Fernàndez-Busquets X. Moles E, et al. Among authors: aldana i. Biomaterials. 2017 Nov;145:178-191. doi: 10.1016/j.biomaterials.2017.08.020. Epub 2017 Aug 15. Biomaterials. 2017. PMID: 28869864
New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.
Ancizu S, Castrillo N, Pérez-Silanes S, Aldana I, Monge A, Delagrange P, Caignard DH, Galiano S. Ancizu S, et al. Among authors: aldana i. Molecules. 2012 Jun 25;17(7):7737-57. doi: 10.3390/molecules17077737. Molecules. 2012. PMID: 22732886 Free PMC article.
58 results
Jump to page